OPLINQRA

EUIPO EUIPO 2024 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OPLINQRA was filed as Word mark on 01/24/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/03/2024. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 018978075
Application date January 24, 2024
Publication date April 26, 2024
Entry date August 3, 2024
Expiration date January 24, 2034

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; pharmaceutical preparations

ID: 11018978075